Incyte Corp (STU:ICY)
€ 100.3 -0.15 (-0.15%) Market Cap: 20.15 Bil Enterprise Value: 16.66 Bil PE Ratio: 16.23 PB Ratio: 4.09 GF Score: 87/100

Incyte Corp at Citi Global Healthcare Conference Transcript

Dec 02, 2025 / 04:15PM GMT
Release Date Price: €87.92 (+0.05%)
David Lebowitz
Citi - Analyst

Okay. All right. Let's get started with the next session of Citi's Global Healthcare conference. It's my great pleasure to have with me the senior management of Incyte Corporation. We have the CEO, Bill Meury; and Pablo Cagnoni, the President of Research and Development. So gentlemen, thank you both so much for taking the time to chat.

Bill Meury
Incyte Corp - President, Chief Executive Officer, Director

It's nice to be here. Thank you.

David Lebowitz
Citi - Analyst

Thank you. All right. Well, let's just kind of kick off the conversation, if we could, with Jakafi and just talk about the overall strategy in terms of Jakafi and what you're doing to drive growth in the company as Jakafi moves beyond the LOE, which obviously is widely expected and you're, of course, very well prepared to address.

Bill Meury
Incyte Corp - President, Chief Executive Officer, Director

Listen, our focus right now is, as you said, transitioning the business from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot